TLDRocket
Sign in

AI & Academia

111 summarised stories about AI & Academia, each linking back to the original source. Browse all topics →

+ Follow this topic

Thursday, 27 August 2026

Expanding our support for scientists

Anthropic 25

Claude is expanding its support for scientific research by launching Claude Science and expanding the AI for Science credits program. It is opening 10,000 free seats and offering premium seats with 5x usage limits for $15 per month under a Claude team plan for one year. Access will broaden over the next months to other scientific fields and more AI-for-Science credits will be available up to $50,000 per project.

The AI ‘Ghosts’ Contaminating Academic Publishing

404 Media 1 month ago 47

A Samsung and University of Warsaw preprint paper argues that large language models repeatedly generate the same nonexistent expert names, which then appear as co-authors across hundreds of AI-generated academic documents. It reports that Zenodo records include 1,655 ghost-authored entries claiming nonexistent journals with fabricated publication dates. This makes academic-record contamination easier to detect via name patterns, but the accuracy may drop as more AI-generated content is added and then retrains future models.

Better answers, broader thinking: What students gain from ChatGPT and critical-thinking training

OpenAI 1 month ago 8

A randomized study assessed how students use ChatGPT alongside critical-thinking training on a real university assignment. It included more than 1,000 students. The results indicate changes in student thinking and performance tied to ChatGPT use plus the training, rather than a purely technical effect.

Ai2 and Providence Swedish Cancer Institute partner to advance AI-assisted scientific discovery

Allen Institute (AI2) 1 month ago 41

Ai2 partnered with the Paul G. Allen Research Center at the Providence Swedish Cancer Institute to run AutoDiscovery on cancer datasets. The collaboration analyzed The Cancer Genome Atlas (TCGA) and found a stronger immune signature in invasive lobular breast cancer, covering about 15% of breast cancer cases diagnosed in the US each year. AutoDiscovery is now being deployed in Providence’s own cloud to support hypothesis generation on protected research and clinical data, with findings validated across independent datasets and lab analyses.

The daily briefing

Every AI story that matters, in your inbox by 8am.

TLDRocket reads all relevant sources, removes duplicate coverage, and summarises the day in two minutes. Follow companies and topics for alerts, or get the briefing in Slack. Free, no spam, unsubscribe anytime.